Comparison between A B Infrabuild IPO and Earum Pharmaceuticals IPO.
IPO Details
A B Infrabuild IPO is a SME Fixed Price IPO proposed to list at NSE SME while Earum Pharmaceuticals IPO is a SME Fixed Price proposed to list at BSE SME.
The total issue size of A B Infrabuild IPO is up to ₹12.19 Cr whereas the issue size of the Earum Pharmaceuticals IPO is up to ₹6.31 Cr. The final issue price of A B Infrabuild IPO is ₹29.00 per share and of Earum Pharmaceuticals IPO is ₹36.00 per share.
A B Infrabuild IPO opens on Jun 28, 2019, while Earum Pharmaceuticals IPO opens on Jun 21, 2019. The closing date of A B Infrabuild IPO and Earum Pharmaceuticals IPO is Jul 03, 2019, and Jun 26, 2019, respectively.
In the A B Infrabuild IPO Retail Individual Investors (RII) are offered 21,04,000 shares while in Earum Pharmaceuticals IPO retail investors are offered 21,04,000 shares. Qualified Institutional Buyers (QIB) are offered in A B Infrabuild IPO and in Earum Pharmaceuticals IPO.
